Today March 28 the Swedish market close at 13.00. Danish and Norweigan markets is closed.

Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.

Quotes for Abera Bioscience AB

Right Now

+/-
0.11
%
2,32%
Latest
4.85
High
4.85
Low
4.78
Volume
894
Turnover (SEK)
4 287
Market Value (MSEK)
74,5
Time (Latest trade)
2024-03-28 11:56

Board

CEO

  • Maria Alriksson

Chairperson of the Board

  • Anders Ericsson

Board

  • Cristina Glad
  • Florence Vicaire
  • Fredrik Juserius

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 10,84 10,84 2023-12-27
Nordnet Pensionsförsäkring 9,16 9,16 2023-12-27
Anders Ericsson med familj 6,18 6,18 2022-05-17
Jan-Willem De Gier 4,13 4,13 2023-12-27
Joen Luirink 4,03 4,03 2023-12-27
Magnus Linderoth 2,43 2,43 2023-12-27
Handelsbanken Liv Försäkring AB 2,27 2,27 2023-12-27
Anders Wall stiftelser 2,21 2,21 2023-12-27
Maths Wahlström 2,15 2,15 2023-12-27
Agneta Albinsson 2,15 2,15 2023-12-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2024-05-14 Delårsrapport 2024-Q1

  • 2024-06-12 Årsstämma 2023

  • 2024-08-21 Delårsrapport 2024-Q2

  • 2024-11-13 Delårsrapport 2024-Q3

  • 2025-02-13 Bokslutskommuniké 2024